QSAR Modeling of a Set of Pyrazinoate Esters as Antituberculosis Prodrugs
✍ Scribed by João P. S. Fernandes; Kerly F. M. Pasqualoto; Veni M. A. Felli; Elizabeth I. Ferreira; Carlos A. Brandt
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 495 KB
- Volume
- 343
- Category
- Article
- ISSN
- 0365-6233
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
N-Acyloxyalkylation using 5-phenyltetrazole as a model compound was investigated as a general means of prodrug modification of the tetrazole ring with a view to change the physicochemical properties for improving biomembrane transport. Pivaloxymethylation gave a mixture of 1- and 2- [(pivaloxy)methy
## Abstract Validation is a crucial aspect for quantitative structure–activity relationship (QSAR) model development. External validation is considered, in general, as the most conclusive proof of predictive capacity of a QSAR model. In the absence of truly external data set, external validation is